U.S. FDA grants fast track designation for ASP0367/MA-0211, a selective PPARδ modulator being developed for the treatment of primary mitochondrial myopathies ... Oct 21
The comprehensive portfolio is the first of several planned plating releases for the distal extremities ... Oct 21
Selecta Biosciences and AskBio receives US FDA rare pediatric disease designation for their gene therapy for methylmalonic acidemia ... Oct 21
-Advertisements-